P53 REAL-WORLD TREATMENT SEQUENCES AND COSTS OF 96 PATIENTS WITH MULTIPLE MYELOMA FROM DIAGNOSIS TO DEATH

• M.R. Seefat,
• D.G.J. Cucchi,
• K. Groen,
• M.L. Donker,
• K.G. van der Hem,
• M. Westerman,
• A.M. Gerrits,
• A. Beeker,
• N. van de Donk,
• H.M. Blommestein,
• S. Zweegman

Affiliations

M.R. Seefat

1 Department of Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands

D.G.J. Cucchi

1 Department of Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands

K. Groen

1 Department of Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands

M.L. Donker

1 Department of Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands

K.G. van der Hem

3 Department of Internal Medicine, Zaans Medical Center, Zaandam, the Netherlands

M. Westerman

4 Department of Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands

A.M. Gerrits

5 Department of Internal Medicine, OLVG, Amsterdam, the Netherlands

A. Beeker

6 Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, the Netherlands

N. van de Donk

1 Department of Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands

H.M. Blommestein

7 Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands

S. Zweegman

1 Department of Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands